Tony Chou

ShiraTronics is working to develop new innovative therapies to combat debilitating chronic migraine headache. We are focused on commercializing novel neuromodulation technologies for this large unmet clinical need.

Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com. Please see Luminopia Directions For Use for more information: luminopia.com/dfu

Carlsmed is a commercial-stage medical technology leader and creator of the personalized spine surgery market with pioneering technology that is transforming spine surgery. The Company has developed the cutting-edge aprevo® Technology Platform that personalizes surgical procedures through a combination of proprietary AI-driven software and patient-specific fusion devices.

At Neuros, our goal is to help amputees with chronic phantom and residual limb pain find relief, decrease pain-induced opioid dependency, improve mental health and restore quality-of-life. We are at work on a novel technology to help make this ambition a reality. Pending FDA Clearance - Investigational Device - Not Intended for Sale

Hinge Health is focused on scaling and automating the delivery of health care, starting with musculoskeletal conditions. Leveraging an AI-powered care model, a wearable device, and access to expert clinicians, Hinge Health delivers personalized, evidence-based care that helps people move beyond pain, improving member outcomes and experiences and reducing costs for clients. The company is headquartered in San Francisco, California. We’re hiring! Join us at hingehealth.com/careers

Accriva Diagnostics is now part of Instrumentation Laboratory. For more information, visit www.instrumentationlaboratory.com

ShiraTronics is working to develop new innovative therapies to combat debilitating chronic migraine headache. We are focused on commercializing novel neuromodulation technologies for this large unmet clinical need.

At InnovaHealth Partners, we believe in the power of medical device innovation to address large unmet surgical needs on a global scale, meaningfully enhancing patient outcomes and furthering value- and evidence-based delivery of care. Headquartered in New York City, our team of seasoned professionals historically has managed over $800 million while working to identify innovative, differentiated investment opportunities in the medical device sector. When combined with strong management, strategic insight and capital, the InnovaHealth portfolio companies unlock substantial value for all stakeholders. Each new investment at our firm is carefully selected and backed by extensive research. Our network of device company managers, physicians and consultants and our dedicated investigation of industry, scientific and financial developments impacting the medical device sector affords our firm unique access to information about the industry and its trends. Our research program generates ideas and plays a crucial role in our investments, strategy and sourcing, establishing us as a leader in medical device private equity. As an industry driven by innovation and shored up by favorable patient volume and demographics, medical devices remain the most compelling segment in healthcare. Our expertise and experience allow us to optimize financial return within this high-growth sector, but also to deliver on our commitment to improving patient outcomes and providing value throughout the healthcare system.

Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com. Please see Luminopia Directions For Use for more information: luminopia.com/dfu

Mobia Medical, Inc. (formerly MicroTransponder, Inc.) is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Companys breakthrough Vivistim® Paired VNS™ System is the first FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Vivistim Paired VNS Therapy combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. For more information, visit Vivistim.com and review safety information at Vivistim.com/safety.

Carlsmed is a commercial-stage medical technology leader and creator of the personalized spine surgery market with pioneering technology that is transforming spine surgery. The Company has developed the cutting-edge aprevo® Technology Platform that personalizes surgical procedures through a combination of proprietary AI-driven software and patient-specific fusion devices.